Home News Maersk Takes the Leadership in COVAXX Distribution

Maersk Takes the Leadership in COVAXX Distribution

COVAXX, a U.S. company developing a multitope synthetic peptide-based vaccine to fight COVID-19 They have announced a global logistics partnership with Maersk, one of the world’s largest shipping and integrated logistics providers. The agreement lays out a framework for all transportation and supply chain services that will be needed to deliver COVAXX’s vaccine candidate UB-612 around the world, once approved by regulatory authorities. Financial terms of the agreement are not disclosed.

The mission of COVAXX is to defeat COVID-19 and ultimately democratize health worldwide. Maersk will help fulfil this mission by overseeing all logistics activities to ensure efficient transportation to developing countries. The agreement provides for end-to-end supply chain management, packing and shipping, via air or ocean, ground transportation, warehouse storage and distribution to facilities to support COVAXX’s requirements for a pharmaceutical grade, temperature-controlled supply chain.

COVAXX is planning to manufacture 100 million doses of UB-612 during early 2021, and a billion doses by the end of 2021. The design of the vaccine components will allow for the use of existing cold-chain storage and distribution channels, as the COVAXX vaccine does not require additional infrastructure such as -80⁰C freezers or liquid nitrogen tanks to store materials at extreme temperatures.

“The COVAXX vaccine is unique in that it can be stored in the fridge you have at home, moved in the same trucks that deliver groceries and administered anywhere you can get a flu shot.” – Lou Reese Co-Chief Executive Officer of COVAXX.

“Our team, which now proudly includes Maersk, is committed to addressing the needs of countries where the greatest unmet needs exist today,” said Mei Mei Hu, Co-Chief Executive Officer of COVAXX.

“To do what is in the best interests of society at this time of the global health crisis, we are aligning with the strongest leaders in their respective industries to meet the large-scale demand and compliance requirements that we expect. It is not enough to focus on vaccine development and approvals. We must work in parallel to establish the infrastructure and partners with the strongest capabilities, like Maersk, to safely deliver our vaccine around the world,” added Mei Mei Hu.

“Efficient and safe delivery of COVID-19 vaccines around the world is the most urgent logistics challenge we face today. A. P. Moller – Maersk is committed to working closely with COVAXX to ensure smooth end-to-end global delivery of this vaccine as soon as it becomes available,” said Rob Townley, Head of Special Project Logistics at Maersk. “Our specialized logistics expertise and the global infrastructure of Maersk make this a perfect match.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Recent posts

RRS Sir David Attenborough Ready for Operation

The new polar research ship, the RRS Sir David Attenborough, left Liverpool cruise terminal on Tuesday 3 November 2020 to begin technical trials. This £200m commitment...

Container Shipping

Container shipping has a history of more than 60 years. More than 60% of the sea freight is containerized cargo. Day by day large...

Stowage Plan for Container Ships

Stowage plan for container ships is the plan prepared on how cargo is loaded and stacked in a container vessel. The stowage plan also...

Intermodal Containers

Intermodal container is another name for the shipping containers. Or containerized cargo care intermodal containers. Once the cargo loaded into a container by a...

Unit Load Device

Unit Load Device (ULD) are specially made containers and pallets to transport cargo via air. All the air freights, mails, and other luggage stuffed...

No Marine Pollution Reported from Dayang Topaz

Petronas has confirmed that an investigation is being carried out on the capsized MV Dayang Topaz at the Baram oil field. In a statement, it...